REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • February 5th, 2021 • FS Development Corp. • Pharmaceutical preparations
THIS REGISTRATION RIGHTS AGREEMENT (this “Agreement”) is entered into as of February 5, 2021, by and among FS Development Corp., a Delaware corporation (the “Company”), the parties listed as Investors on Schedule I hereto (each, an “Investor” and collectively, the “Investors”) and Gemini Therapeutics, Inc., a Delaware company (“Gemini”).
ESCROW AGREEMENTEscrow Agreement • February 5th, 2021 • FS Development Corp. • Pharmaceutical preparations • New York
THIS ESCROW AGREEMENT (“Agreement”) is made and entered into as of February 5, 2021, by and between: FS Development Holdings, LLC, a Delaware limited liability company (“Sponsor”), FS Development Corp., a Delaware corporation (“Parent”), Shareholder Representative Services LLC, a Colorado limited liability company solely in its capacity as the representative of the Company Securityholders (the “Stockholder Representative”), solely in its capacity as the representative, agent and attorney-in-fact of the stockholders of the Company, and Continental Stock Transfer & Trust Company, a New York corporation (the “Escrow Agent”).
